Format

Send to

Choose Destination
Hematol Oncol. 2018 Feb;36(1):24-27. doi: 10.1002/hon.2419. Epub 2017 May 23.

Are we ready to take full advantage of patient-derived tumor xenograft models?

Author information

1
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
2
Department of Molecular Biotechnology and Health Science and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy.
3
Department of Pathology, and New York University Cancer Center, New York University School of Medicine, New York, NY, USA.
PMID:
28543217
DOI:
10.1002/hon.2419
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center